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EDITORIAL 
Progress Toward A New Wart Biology 
Experimental study of wart disease has entered a new era of exciting 
molecular and immunologic observation well-illustra ted by the paper 
of J ablonska and co-workers [1] in this issue of the J ournal. For years 
virologists la rgely avoided work with papilloma viruses mostly out of 
frustratio n engendered by failure to propagate virus in t issue cul ture 
systems. Clinicians, on the other hand, often recognized the potent ia ls 
of wart biology but lacked the methodology to test their hypotheses. 
Clinicians and molecula r biologists are now moving forward in close 
coop era t ion, and progress can be measured by the records of an 
international conference held in Lyon, France, in 1975 [2] and a more 
r ecent workshop sponsored by the National Cancer Institute in Mobile, 
Alabama, this past summer. 
A key to progress has been the recognition of the plura li ty of human 
papiIlomaviruses (HPVs). Gissman, zur Hausen and their German co-
work ers [3, 4] , and Orth and co-workers [5, 6] in France have identified 
severa l HPVs each wi th a dis tinct DNA genome and characteristic 
typ e -specific antigens. The number of HPVs is increasing as more 
individual viral isolates are studied, and it may be some time before a 
fina l classification is crystalized 0 1' before we defin e common gene 
sequences or antigenic dete rminants shared by virus types. Meanwhile, 
t h e new technology a llows for analysis of the HPV genome with 
bacteria l restriction endonucleases giving a " fingerprint" characteristic 
for each virus type. The HPV DNA or complementary RNA may be 
rad io labeled and used for molecula r hybridization with free vira l DNA 
or cellular DNA. We can go pl'Ospecting for the HPV genome in 
papillomas where virion assembly cannot be detected by electron 
m ic roscopic examination, e.g. , laryngeal papillomas or anogeni tal warts, 
and we can study carcinomas seen in close association with warts. The 
clinical course ofvel'l'ucous carcinomas, carcinoma- in-s itu in the genita l 
area, and carcinomas occurring in pa tients with epidermodysplas ia 
verruciformis (I~V) suggests that HPVs playa substantive role in the 
process of ma lignant transformation. Virions cannot be detected in 
s u c h carcinomas, but methods of molecular hybridization may detect 
t h e HPV genome. Failure to detect HPV DNA in wart-related carci-
nomas [7] may re flect the lack of type-specificity of earlier molecular 
probes. 
The immunologic s tudy of wart disease is a lso rapidly advancing. 
Progressive, unrelenting wart disease in association with clinica l im-
munosuppression has become a fa irly commonplace observa tion. Spec-
ula t ion about the role of immunity in the progression or spontaneous 
regression of warts at one time centered al'Ound futile attempts to 
demonstrate tumor-specific cellula r antigens s imilar to those responsi-
ble for the regression of animal papovavirus (SV40 and polyoma) 
t umors. Recent focus upon viral structural antigens has been more 
productive. Morison demonstra ted heigh tened responses of ceIl -me-
diated immunity (CMI) to vira l ant igens near the time of regression [8] 
a nd Pyrhonen and Johansson [9J found a s imila r correlation between 
regression and the appearance of complement-fixing IgG antibodies to 
viru s. Data from several laborato ries supports the concept that either 
CMI , or antibody, or both may be responsible for regression. 
EV is an ideal model of wart disease. The study of only a few EV 
patients has led to recognition of new HPVs [10, 11] and the associated 
a bbe rations of host immunity [1 2, 13l Experiments are in progress 
u s ing EV patients to explore the role of virus and immunity in patho-
genesis of benign papillomas and in malignant transformation. EV is a 
rare experiment in nature but is similar to infection of rabbi ts with wild 
cottontail rabbit (Shope) papilloma virus; rabbit papillomas regress or 
proceed to squamous ce ll carcinomas depending on the immune re-
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sponse of the host. The application of new technology to studies of 
ra bbi t and bovine papilloma viruses may provide fresh insights in to 
human d isease. 
Ultimately, we must. understand t.he funda mental in terre lationship 
between virus and kerat inocyte. Studies of other DNA viruses show 2 
possible virus-cell in teractions; one where productive virion assembly 
occm s and one where the vira l genome is integrated and replicated in 
the a bsence of assembly. Neither possibili ty seems entirely tenable in 
the case of papillomavirus, where virion assembly a nd free vira l DNA 
may 0 1' may not be present. Once we understand the mechanisms of 
virus-ce ll inte ractions, new methods of therapy may evolve. We may 
replace the destructive and often unsuccessful treatment of warts with 
specific molecular and immunologic therapy. It is t his knowledge which 
will eventua lly lead to cl inical solutions to t.he ever difficul t problem of 
eradicating warts. 
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